Quotes 5-day view Delayed Nyse
01/19/2021
01/20/2021
01/21/2021
01/22/2021
01/25/2021
Date
87.91(c)
88.1(c)
87.23(c)
85.52(c)
85.89(c)
Last
1 976 894
3 561 984
1 796 317
3 278 941
3 297 685
Volume
+0.05%
+0.22%
-0.99%
-1.96%
+0.43%
Change
Sales 2020
4 385 M
-
-
Net income 2020
819 M
-
-
Net cash position 2020
815 M
-
-
P/E ratio 2020
64,9x
Yield 2020
-
Sales 2021
5 098 M
-
-
Net income 2021
1 249 M
-
-
Net cash position 2021
1 588 M
-
-
P/E ratio 2021
42,6x
Yield 2021
-
Capitalization
53 531 M
53 531 M
-
EV / Sales 2020
12,0x
EV / Sales 2021
10,2x
Nbr of Employees
13 900
Free-Float
97,4%
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- hemodynamic monitoring systems (61.4%);
- heart valves and surgery products (20.4%);
- other (18.1%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the...
Notations Surperformance© of Edwards Lifesciences Corporation
Trading Rating :
Investor Rating :
All news about EDWARDS LIFESCIENCES CORPORATION
News in other languages on EDWARDS LIFESCIENCES CORPORATION
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION
Chart EDWARDS LIFESCIENCES CORPORATION
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
Short Term Mid-Term Long Term Trends Neutral Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
26
Average target price
93,43 $
Last Close Price
85,89 $
Spread / Highest target
29,2%
Spread / Average Target
8,78%
Spread / Lowest Target
-25,5%
Please enable JavaScript in your browser's settings to use dynamic charts.